DL

Dale Lincoln Ludwig

IM Imclone: 4 patents #1 of 40Top 3%
EL Eli Lilly: 4 patents #824 of 2,858Top 30%
ZY Zymeworks: 3 patents #21 of 65Top 35%
AP Actinium Phamaceuticals: 1 patents #13 of 22Top 60%
UW University Of Washington: 1 patents #985 of 2,234Top 45%
IM Immunogen: 1 patents #78 of 119Top 70%
EU Elanco Us: 1 patents #36 of 75Top 50%
II Imclone Systems Incorporated: 1 patents #9 of 30Top 30%
📍 Denville, NJ: #34 of 282 inventorsTop 15%
🗺 New Jersey: #8,044 of 69,400 inventorsTop 15%
Overall (All Time): #441,434 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11912780 Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies Mark Berger, Keisha Thomas, Sandesh Seth 2024-02-27
11351251 Anti-PD-L1-anti-TIM-3 bispecific antibodies Yiwen Li, Yang Shen, Yi Zhang, Igor Edmondo Paolo D'Angelo 2022-06-07
11203640 Checkpoint inhibitor bispecific antibodies Michael D. Kalos, Yiwen Li, Yang Shen, Igor Edmondo Paolo D'Angelo, Gregory D. Plowman 2021-12-21
10711066 Anti-canine platelet derived growth factor receptor alpha antibody Douglas Bryan Burtrum, Juqun Shen, Cheng-I Wang 2020-07-14
10279034 Anti-PD-L1-anti-TIM-3 bispecific antibodies Yiwen Li, Yang Shen, Yi Zhang, Igor Edmondo Paolo D'Angelo 2019-05-07
10214586 PD-L1 antibodies Marshall D. Snavely, Yiwen Li, Juqun Shen, Vera Molkenthin 2019-02-26
9375488 Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment Paul J. Balderes, Scott W. Eastman, Hans K. Erickson, Christopher M. Moxham, Gregory D. Plowman +1 more 2016-06-28
7972600 IGF-IR antagonists as adjuvants for treatment of prostate cancer Stephen R. Plymate 2011-07-05
7968093 Fully human antibodies directed against the human insulin-like growth factor-1 receptor 2011-06-28
7638605 Fully human antibodies directed against the human insulin-like growth factor-1 receptor 2009-12-29
6410723 VDUP1 promoter and methods of use thereof 2002-06-25